BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Biotech Bay

  SI-BONE’s New iFuse-Navigation Set and iFuse-3D Fenestrated SI Joint Fusion Implant to be Featured at the 2017 North American Spine Society Annual Meeting

  SI-BONE announced its new iFuse-Navigation Set and proprietary 3D printed iFuse-3D fenestrated triangular titanium implant, will be featured at this year’s North American Spine Society (NASS) annual meeting in Orlando, FL.

  October 23, 2017

   · 

  5 min read
• Business

  Biogen and Eisai Expand Alzheimer’s R&D Collaboration

  Under the deal, Eisai has exercised its option to co-develop and co-promote aducanumab, Biogen’s investigational anti-amyloid beta antibody for patients with Alzheimer’s disease.

  October 23, 2017

   · 

  10 min read
• Business

  Henry Schein to Webcast Third Quarter 2017 Conference Call on Monday, November 6, 2017 at 10:00 A.M. ET

  Henry Scheinl announced today that it will release its third quarter 2017 financial results before the stock market opens on Monday, November 6, 2017, and will provide a live webcast of its earnings conference call on the same day beginning at 10:00 a.m. Eastern time.

  October 23, 2017

   · 

  2 min read
• Business

  Almac Group Announces Successful MHRA Inspection at Charnwood Facilities

  This successful inspection provides Almac Pharma Services with the necessary licenses to develop, manufacture and pack non-potent and potent, solid oral drug products for clinical trials and commercial supply at the Charnwood site.

  October 23, 2017

   · 

  2 min read
• Drug Development

  W. L. Gore & Associates, Inc. Release: Physicians Report Early Successes Across Multiple Applications in First-in-Human Uses of GORE® SYNECOR Preperitoneal Biomaterial Hernia Repair Device

  Physicians among the first to use the GORE SYNECOR Preperitoneal Biomaterial, a unique hybrid device for hernia repair, are reporting positive experiences in using the device in a range of applications, according to W. L. Gore & Associates (Gore).

  October 23, 2017

   · 

  5 min read
• 

  Biotech Bay

  Bay Area’s Claret Medical Nabs $14.5M

  The investment was led by Lightstone Ventures, with participation from existing investors Easton Capital, HealthCor Partners, Incept LLC and Sante Ventures.

  October 23, 2017

   · 

  3 min read
• 

  FDA

  Quidel Wins FDA Nod for Its Point-of-Care Sofia Lyme FIA

  The test is intended for use with the Sofia analyzer to aid in the diagnosis of Lyme disease.

  October 23, 2017

   · 

  8 min read
• BioMidwest

  Abbott Launches the First and Only Smartphone Compatible Insertable Cardiac Monitor in the U.S.

  Abbotthas secured FDFA clearance for the Confirm Rx Insertable Cardiac Monitor (ICM), the world’s first and only smartphone compatible ICM designed to help physicians remotely identify cardiac arrhythmias.

  October 23, 2017

   · 

  3 min read
• Business

  CytoSen Therapeutics Appoints CEO and Scientific Advisory Board

  CytoSen Therapeutics announced today the appointment of Jak Knowles, M.D. as CEO and five new members to the company’s scientific and medical advisory board.

  October 23, 2017

   · 

  5 min read
• Business

  AMPAC Fine Chemicals Announces Recent Promotions in Their Executive Team

  AMPAC Fine Chemicals is pleased to announce that Don Whiteaker has been promoted to the position of VP, Supply Chain and Dr. Jeff Butler has been promoted to the position of Executive Director, Project Management.

  October 23, 2017

   · 

  2 min read